Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Global Finance Herald.
Press releases published on June 17, 2025
Aldebaran Reports Infill Drilling Results from Eleven Holes at the Altar Copper-Gold Project in San Juan Argentina
GlobeNewswire
·
June 17, 2025
VANCOUVER, British Columbia, June 17, 2025 (GLOBE NEWSWIRE) -- Aldebaran Resources Inc. (“Aldebaran” or the “Company”) (TSX-V: ALDE, OTCQX: ADBRF) is pleased to provide results of 11 holes from the in-fill drilling program currently being completed at the …
Relmada Therapeutics Appoints Urology Expert Raj S. Pruthi, MD as CMO-Urology
GlobeNewswire
·
June 17, 2025
Dr. Pruthi brings vast clinical development experience advancing novel therapies for NMIBC to Relmada and the NDV-01 program Phase 3 trial for NDV-01 expected to begin in H1 2026 CORAL GABLES, Fla., June 17, 2025 (GLOBE NEWSWIRE) -- Relmada Therapeutics, …
Regenx Tech Provides Operational Update
GlobeNewswire
·
June 17, 2025
EDMONTON, Alberta, June 17, 2025 (GLOBE NEWSWIRE) -- Regenx Tech Corp., (the "Company" or "Regenx") (CSE: RGX) (OTCQB: RGXTF) (FSE: YRS WKN: A2DSW3) is providing an update on the status of the restart of operations at its new facility in Newport, Tennessee …
DAVIDsTEA Delivers Strong Start to Fiscal 2025 with Higher Margins and Profitability Gains in Q1
GlobeNewswire
·
June 17, 2025
Q1 sales reached $13.5 million, representing a 0.6% increase year-over-year Gross profit margin rose to 51.1%, up from 43.3% in Q1 2024 Net loss significantly reduced to $0.2 million compared to $2.6 million in Q1 2024 Adjusted EBITDA turned positive at $1 …
DAVIDsTEA démarre l'exercice 2025 en force avec des marges plus élevées et des gains de rentabilité au T1
GlobeNewswire
·
June 17, 2025
Au T1, les ventes ont atteint 13,5 M$, soit une augmentation de 0,6 % en glissement annuel. La marge brute a augmenté pour atteindre 51,1 %, contre 43,3 % au T1 2024. La perte nette a été considérablement réduite pour atteindre 0,2 M$, contre 2,6 M$ au T1 …
Troilus Drills 78.38 g/t AuEq Over 2 m, Including 153.73 g/t AuEq Over 1 m in the Southwest Zone
GlobeNewswire
·
June 17, 2025
MONTREAL, June 17, 2025 (GLOBE NEWSWIRE) -- Troilus Gold Corp. (“Troilus” or the “Company”, TSX: TLG; OTCQX: CHXMF; FSE: CM5R) is pleased to announce the final assay results from the Southwest Zone (“Southwest”) as part of its ongoing 2025 Exploration …
Troilus Intercepte 78,38 g/t d’équ.-Or Sur 2 m, Incluant 153,73 g/t d’équ.-Or Sur 1 m dans la Zone Southwest
GlobeNewswire
·
June 17, 2025
MONTRÉAL, 17 juin 2025 (GLOBE NEWSWIRE) -- Troilus Gold Corp. (« Troilus » ou la « Société ») (TSX: TLG; OTCQX: CHXMF; FSE: CM5R) a le plaisir d’annoncer les résultats d’analyse finaux provenant de la zone Southwest («Southwest») dans le cadre de sa …
Koryx Copper Provides Project Development Update for the Haib Copper Project, Southern Namibia
GlobeNewswire
·
June 17, 2025
Highlights Metallurgical testwork program with encouraging preliminary results including 89% average flotation recovery from 120-150µm grind size producing clean concentrate with grade of 20-25% Cu. Pre-concentration and heap leach testwork ongoing with …
Ventyx Biosciences Announces Positive Top-Line Data from its Phase 2a Safety and Biomarker Trial Evaluating VTX3232 in Patients with Early-Stage Parkinson’s Disease
GlobeNewswire
·
June 17, 2025
The study met its primary goal of establishing safety and tolerability of VTX3232 in patients with early-stage Parkinson’s disease CSF and plasma exposures reinforce VTX3232’s potential as a once-daily oral therapy for neurodegenerative diseases VTX3232 …
Dyne Therapeutics Announces FDA Breakthrough Therapy Designation for DYNE-101 and Updated Plan for Accelerated Approval in DM1 Following Type C Meeting
GlobeNewswire
·
June 17, 2025
- Based on Type C meeting and new data, Dyne submitted revised ACHIEVE trial protocol to FDA elevating vHOT to primary endpoint for U.S. Accelerated Approval - - New positive clinical data from Phase 1/2 ACHIEVE trial support vHOT as early indicator of …
Vireo Growth Inc. Provides Corporate Update Post Closing of All Merger Transactions
GlobeNewswire
·
June 17, 2025
MINNEAPOLIS, June 17, 2025 (GLOBE NEWSWIRE) -- Vireo Growth Inc. (“Vireo” or the “Company”) (CSE: VREO; OTCQX: VREOF), today announced a series of corporate updates following the closing of all its previously-announced definitive merger agreements, which …
Material Update on Off-Market Takeover by Bastion Mining
GlobeNewswire
·
June 17, 2025
TORONTO, Canada, June 17, 2025 (GLOBE NEWSWIRE) -- Xanadu Mines Ltd (ASX: XAM, TSX: XAM) (Xanadu or the Company) today provides an important update in relation to the off-market takeover offer by Bastion Mining Pte. Ltd. UEN 202512367N (Bastion) to acquire …
Surge Copper Reports Excellent Metallurgical Results Supporting Pre-Feasibility Advancement at Berg Project
GlobeNewswire
·
June 17, 2025
Locked cycle tests exceed 90% copper and molybdenum recoveries and confirm clean final products with high separation efficiency Vancouver, British Columbia, June 17, 2025 (GLOBE NEWSWIRE) -- Surge Copper Corp. (TSXV: SURG) (OTCQB: SRGXF) (Frankfurt: G6D2) …
Oncocyte Changes Name to Insight Molecular Diagnostics Inc. (iMDx), Moves Headquarters to Nashville
GlobeNewswire
·
June 17, 2025
New name aligns with mission to deliver precision biomarker-based testing for both transplant and oncology care iMDx sponsoring GraftAssureIQ™ research-use-only kits at transplant labs globally Exhibiting at European Society of Organ Transplantation (ESOT) …
Fountain Asset Corp. Announces Normal Course Issuer Bid
GlobeNewswire
·
June 17, 2025
TORONTO, June 17, 2025 (GLOBE NEWSWIRE) -- Fountain Asset Corp. (TSXV: FA) (“Fountain”) announced today its intention to effect a normal course issuer bid through the facilities of the TSX Venture Exchange, subject to receipt of regulatory approval. Upon …
Mineralys Therapeutics Announces Positive Topline Results from Phase 2 Explore-CKD Trial of Lorundrostat for the Treatment of Hypertension in Subjects with CKD and Albuminuria
GlobeNewswire
·
June 17, 2025
– Explore-CKD met its primary endpoint; lorundrostat 25 mg once daily achieved a 9.3 mmHg reduction in systolic blood pressure, and a 7.5 mmHg placebo-adjusted reduction (p=0.0024) at four weeks – – Lorundrostat showed a clinically meaningful reduction in …
Canadian Cannabis Companies Go Global Amid Rising Export Demand
GlobeNewswire
·
June 17, 2025
Toronto, ON, June 17, 2025 (GLOBE NEWSWIRE) -- Canada is a global leader in regulated medical cannabis exports with federal legalization reinforcing its position on the international stage and giving producers a strong advantage abroad. But as global …
Beneficient Announces Court Approval of GWG Litigation Settlement
GlobeNewswire
·
June 17, 2025
DALLAS, June 17, 2025 (GLOBE NEWSWIRE) -- Beneficient (NASDAQ: BENF) (“Beneficient,” “Ben” or the “Company”), a technology-enabled platform providing exit opportunities and primary capital solutions and related trust and custody services to holders of …
OROCO ANNOUNCES PRIVATE PLACEMENT
GlobeNewswire
·
June 17, 2025
VANCOUVER, Canada, June 17, 2025 (GLOBE NEWSWIRE) -- Oroco Resource Corp. (TSX-V: OCO, OTC: ORRCF) (“Oroco” or the “Company”) is pleased to announce a non-brokered private placement (the “Offering”) of up to 5,000,000 units of the Company (each, a “Unit”) …
Mobilicom to Participate in the iAccess Alpha Virtual Best Ideas Summer Investment Conference 2025 on June 24–25, 2025
GlobeNewswire
·
June 17, 2025
Mobilicom’s corporate presentation and investment thesis can be viewed here: LINK Palo Alto, California, June 17, 2025 (GLOBE NEWSWIRE) -- Mobilicom Limited (Nasdaq: MOB), a provider of cybersecurity and robust solutions for drones and robotics, today …